2019 House Bill 4225 / Public Act 43

Exempt hospice painkiller from “bona fide prescriber-patient relationship" requirement

Introduced in the House

Feb. 21, 2019

Introduced by Rep. Bronna Kahle (R-57)

To establish a hospice exception from a law that prohibits prescribers who do not have a “bona fide prescriber-patient relationship" from prescribing controlled substance painkillers. This restriction requires a medical service provider to have reviewed a patient’s relevant medical records, and completed a full medical history and current condition assessment including an examination. The proposed exception is intended to let hospice care providers adjust medication to the meet serious and rapidly changing needs of a dying individual.

Referred to the Committee on Health Policy

March 14, 2019

Reported without amendment

Refer to the Committee on Ways and Means with the recommendation that the substitute (H-1) be adopted.

Referred to the Committee on Ways and Means

April 9, 2019

Reported without amendment

With the recommendation that the substitute (H-2) be adopted and that the bill then pass.

April 11, 2019

Passed in the House 110 to 0 (details)

Received in the Senate

April 16, 2019

Referred to the Committee on Health Policy and Human Services

June 19, 2019

Passed in the Senate 37 to 0 (details)

To establish a hospice exception from a law that prohibits prescribers who do not have a “bona fide prescriber-patient relationship" from prescribing controlled substance painkillers. This restriction requires a medical service provider to have reviewed a patient’s relevant medical records, and completed a full medical history and current condition assessment including an examination. The proposed exception is intended to let hospice care providers adjust medication to the meet serious and rapidly changing needs of a dying individual.

Received in the House

June 19, 2019

June 20, 2019

Passed in the House 109 to 0 (details)

Signed by Gov. Gretchen Whitmer

July 8, 2019